Review: could Citalopram Hydrobromide cause Cholelithiasis?


Cholelithiasis is found among people who take Citalopram Hydrobromide, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Yasmin, and have Depression . We study 23,048 people who have side effects while taking Citalopram hydrobromide from FDA and social media. Among them, 154 have Cholelithiasis. Find out below who they are, when they have Cholelithiasis and more.

You are not alone

Join a support group for people who take Citalopram hydrobromide and have Cholelithiasis >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>

Citalopram Hydrobromide

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. (latest outcomes from Citalopram hydrobromide 24,725 users)


Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts) has been reported by people with breathing difficulty, hypotension, renal impairment, abdominal pain, diarrhea (latest reports from 27,789 Cholelithiasis patients).

On Aug, 25, 2016

23,048 people reported to have side effects when taking Citalopram Hydrobromide.
Among them, 154 people (0.67%) have Cholelithiasis

Number of reports submitted per year:

Could Citalopram hydrobromide cause Cholelithiasis?

Time on Citalopram Hydrobromide when people have Cholelithiasis *:

  • < 1 month: 8.33 %
  • 1 - 6 months: 41.67 %
  • 6 - 12 months: 8.33 %
  • 1 - 2 years: 16.67 %
  • 2 - 5 years: 25.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Cholelithiasis when taking Citalopram Hydrobromide *:

  • female: 75.84 %
  • male: 24.16 %

Age of people who have Cholelithiasis when taking Citalopram Hydrobromide *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 3.76 %
  • 20-29: 15.04 %
  • 30-39: 18.8 %
  • 40-49: 11.28 %
  • 50-59: 11.28 %
  • 60+: 39.85 %

Top conditions involved for these people *:

  • Depression (37 people)
  • Contraception (23 people)
  • Anxiety (18 people)
  • Premenstrual Syndrome (17 people)
  • Multiple Myeloma (17 people)

Top co-used drugs for these people *:

  • Yasmin (45 people)
  • Celexa (41 people)
  • Furosemide (36 people)
  • Nitroglycerin (27 people)
  • Aredia (27 people)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Cholelithiasis when taking Citalopram hydrobromide?

Browse all side effects of Citalopram hydrobromide

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Cholelithiasis


Could your condition cause Cholelithiasis


Can you answer these questions?

More questions for: Citalopram hydrobromide, Cholelithiasis

You may be interested in these reviews

More reviews for: Citalopram hydrobromide, Cholelithiasis

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.